A vaccine that could prevent young women from developing most cases of cervical cancer could be on the market within a few years.Researchers are testing dozens of vaccines against different types of cancer but those that protect women against strains of the human papillomavirus (HPV), which are linked to more than 70 percent of cervical cancer cases, are the most advanced.
